Free Trial

Addus HomeCare Corporation $ADUS Shares Sold by NFJ Investment Group LLC

Addus HomeCare logo with Medical background

Key Points

  • NFJ Investment Group LLC reduced its holdings in Addus HomeCare Corporation by 8.8% during Q1, selling 7,057 shares and retaining a total of 72,791 shares valued at approximately $7.2 million.
  • Insider activity included CEO R Dirk Allison selling 25,000 shares for about $2.87 million, representing a 13.06% decrease in his holdings.
  • Analysts have a consensus price target of $138.89 for Addus HomeCare, with some firms rating the stock as a buy and others offering price targets ranging from $109.00 to $140.00.
  • Interested in Addus HomeCare? Here are five stocks we like better.

NFJ Investment Group LLC cut its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 8.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 72,791 shares of the company's stock after selling 7,057 shares during the period. NFJ Investment Group LLC owned approximately 0.40% of Addus HomeCare worth $7,198,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Premier Fund Managers Ltd purchased a new stake in shares of Addus HomeCare in the first quarter valued at approximately $726,000. Deutsche Bank AG grew its position in shares of Addus HomeCare by 50.0% in the fourth quarter. Deutsche Bank AG now owns 16,354 shares of the company's stock valued at $2,050,000 after purchasing an additional 5,448 shares in the last quarter. Bank of America Corp DE grew its position in shares of Addus HomeCare by 273.6% in the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after purchasing an additional 128,211 shares in the last quarter. HighTower Advisors LLC grew its position in shares of Addus HomeCare by 62.4% in the first quarter. HighTower Advisors LLC now owns 4,671 shares of the company's stock valued at $462,000 after purchasing an additional 1,795 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in shares of Addus HomeCare by 77.6% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 8,836 shares of the company's stock valued at $1,108,000 after purchasing an additional 3,862 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Trading Up 1.2%

NASDAQ:ADUS traded up $1.37 during trading hours on Friday, reaching $113.22. 88,436 shares of the stock were exchanged, compared to its average volume of 138,765. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The business has a 50-day moving average of $112.01 and a two-hundred day moving average of $106.92. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 24.99, a PEG ratio of 1.73 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. During the same period in the prior year, the firm earned $1.35 earnings per share. The firm's revenue was up 21.8% compared to the same quarter last year. On average, equities analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, Director Veronica Hill-Milbourne sold 1,571 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the transaction, the director directly owned 5,067 shares in the company, valued at $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Poff sold 7,739 shares of the company's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the transaction, the executive vice president owned 56,980 shares in the company, valued at $6,656,403.60. This trade represents a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,310 shares of company stock worth $3,958,375 over the last ninety days. Corporate insiders own 4.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on ADUS shares. Barclays upped their price target on Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a research report on Tuesday, August 19th. Royal Bank Of Canada increased their price objective on Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research report on Friday, August 22nd. Macquarie reiterated an "outperform" rating and issued a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Wednesday, July 16th. Finally, Stephens reiterated an "overweight" rating and issued a $140.00 price objective on shares of Addus HomeCare in a research report on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Addus HomeCare presently has an average rating of "Buy" and an average price target of $138.89.

Get Our Latest Analysis on Addus HomeCare

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.